Neuroprotective effects of coffee bioactive compounds: a review

K Socała, A Szopa, A Serefko, E Poleszak… - International journal of …, 2020 - mdpi.com
Coffee is one of the most widely consumed beverages worldwide. It is usually identified as a
stimulant because of a high content of caffeine. However, caffeine is not the only coffee …

Molecular pathological classification of neurodegenerative diseases: turning towards precision medicine

GG Kovacs - International journal of molecular sciences, 2016 - mdpi.com
Neurodegenerative diseases (NDDs) are characterized by selective dysfunction and loss of
neurons associated with pathologically altered proteins that deposit in the human brain but …

Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43

YX Jiang, Q Cao, MR Sawaya, R Abskharon, P Ge… - Nature, 2022 - nature.com
Frontotemporal lobar degeneration (FTLD) is the third most common neurodegenerative
condition after Alzheimer's and Parkinson's diseases. FTLD typically presents in 45 to 64 …

Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes

ITS Coyle-Gilchrist, KM Dick, K Patterson… - Neurology, 2016 - AAN Enterprises
Objectives: To estimate the lifetime risk, prevalence, incidence, and mortality of the principal
clinical syndromes associated with frontotemporal lobar degeneration (FTLD) using revised …

C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD

Y Liu, A Pattamatta, T Zu, T Reid, O Bardhi… - Neuron, 2016 - cell.com
To define how the C9orf72 GGGGCC expansion mutation causes ALS/FTD and to facilitate
therapy development, a mouse model that recapitulates the molecular and phenotypic …

Molecular pathology of neurodegenerative diseases: principles and practice

GG Kovacs - Journal of clinical pathology, 2019 - jcp.bmj.com
Neurodegenerative diseases are characterised by selective dysfunction and progressive
loss of synapses and neurons associated with pathologically altered proteins that deposit …

Alzheimer's disease

CA Lane, J Hardy, JM Schott - European journal of neurology, 2018 - Wiley Online Library
Alzheimer's disease, the commonest cause of dementia, is a growing global health concern
with huge implications for individuals and society. In this review, current understanding of …

Imaging and fluid biomarkers in frontotemporal dementia

LH Meeter, LD Kaat, JD Rohrer… - Nature Reviews …, 2017 - nature.com
Frontotemporal dementia (FTD), the second most common type of presenile dementia, is a
heterogeneous neurodegenerative disease characterized by progressive behavioural …

Frontotemporal dementia: latest evidence and clinical implications

JJ Young, M Lavakumar, D Tampi… - Therapeutic …, 2018 - journals.sagepub.com
Background: Frontotemporal dementia (FTD) describes a cluster of neurocognitive
syndromes that present with impairment of executive functioning, changes in behavior, and …

TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression …

F Laferrière, Z Maniecka, M Pérez-Berlanga… - Nature …, 2019 - nature.com
Accumulation of abnormally phosphorylated TDP-43 (pTDP-43) is the main pathology in
affected neurons of people with amyotrophic lateral sclerosis (ALS) and frontotemporal lobar …